The Drug Discovery Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Drug Discovery Market:
https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

According to The Business Research Company’s Drug Discovery Global Market Report 2024, The drug discovery market size has grown rapidly in recent years. It will grow from $98.01 billion in 2023 to $111.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to advancements in genomics and proteomics, expanding prevalence of chronic diseases, emergence of biopharmaceuticals.

The drug discovery market size is expected to see rapid growth in the next few years. It will grow to $192.2 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to precision medicine adoption, focus on rare diseases, expansion of personalized therapies. Major trends in the forecast period include collaborative drug discovery models, focus on rare diseases and orphan drugs, integration of multi-omics data, rapid adoption of organoids and 3D cell culture models, advancements in virtual screening.

Rising healthcare expenditure is expected to propel the drug discovery market going forward. Countries around the world are spending a major share of their GDP on healthcare expenses which include hospital care, physician and clinical services, other professional services, dental services, other health, residential, and personal care, home health care, nursing care facilities, and continuing care retirement communities, prescription drugs, and others. Drug discovery holds a significant part of the health expenditure, as it is required to treat diseases and prolong life. There is an increasing need for new drugs to treat new diseases. For instance, in December 2023, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, in 2022, US healthcare spending increased by 4.1% to $4.5 trillion, or $13,493 per person. Health spending accounted for 17.3% of the country's Gross Domestic Product. Therefore, the rise in healthcare expenditures is driving the growth of the drug discovery market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

The drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule, Large Molecule
2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation
3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies
4) By Therapeutic Area: Oncology, Neurology, Infectious and Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas
5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Major companies operating in the drug discovery market are developing innovative products such as drug discovery accelerator for creating advanced drug models. Drug discovery accelerators are entities, initiatives, or programs designed to speed up the process of finding and developing new drugs. For instance, in September 2023, Novo Nordisk and Evotec have launched LAB eN², a translational drug discovery accelerator that aims to nurture preclinical research from academic institutions for the development of novel therapeutics. The focus of the collaboration is to accelerate the translation of academic ideas to therapeutic product candidates in the cardiometabolic space as well as rare blood and endocrine disorders.

The drug discovery market report table of contents includes:
1. Executive Summary
2. Drug Discovery Market Characteristics
3. Drug Discovery Market Trends And Strategies
4. Drug Discovery Market - Macro Economic Scenario
5. Global Drug Discovery Market Size and Growth
......................
31. Drug Discovery Market Other Major And Innovative Companies
32. Global Drug Discovery Market Competitive Benchmarking
33. Global Drug Discovery Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Drug Discovery Market
35. Drug Discovery Market Future Outlook and Potential Analysis

Read Related Topics:
https://goodprnews.com/coffee-machines-global-market-size/
https://goodprnews.com/cognitive-services-global-market-size/
https://goodprnews.com/coil-coatings-global-market-size/
https://topprnews.com/coffee-machines-global-market-share/
https://topprnews.com/cognitive-services-global-market-share/
https://topprnews.com/coil-coatings-global-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model